GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Flerie AB (OSTO:FLERIE) » Definitions » Financial Strength

Flerie AB (OSTO:FLERIE) Financial Strength : 8 (As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Flerie AB Financial Strength?

Flerie AB has the Financial Strength Rank of 8. It shows strong financial strength and is unlikely to fall into distressed situations.

Good Sign:

Flerie AB shows strong financial strength.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.

Flerie AB did not have earnings to cover the interest expense. Flerie AB's debt to revenue ratio for the quarter that ended in Jun. 2024 was 2.75. As of today, Flerie AB's Altman Z-Score is 58.00.


Competitive Comparison of Flerie AB's Financial Strength

For the Biotechnology subindustry, Flerie AB's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Flerie AB's Financial Strength Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Flerie AB's Financial Strength distribution charts can be found below:

* The bar in red indicates where Flerie AB's Financial Strength falls into.



Flerie AB Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

Flerie AB's Interest Expense for the months ended in Jun. 2024 was kr-1.40 Mil. Its Operating Income for the months ended in Jun. 2024 was kr-85.50 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was kr0.70 Mil.

Flerie AB's Interest Coverage for the quarter that ended in Jun. 2024 is

Flerie AB did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

Flerie AB's Debt to Revenue Ratio for the quarter that ended in Jun. 2024 is

Debt to Revenue Ratio=Total Debt (Q: Jun. 2024 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.4 + 0.7) / 0.4
=2.75

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Flerie AB has a Z-score of 58.00, indicating it is in Safe Zones. This implies the Z-Score is strong.

Good Sign:

Altman Z-score of 58 is strong.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Flerie AB  (OSTO:FLERIE) Financial Strength Explanation

The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.

Flerie AB has the Financial Strength Rank of 8. It shows strong financial strength and is unlikely to fall into distressed situations.


Flerie AB Financial Strength Related Terms

Thank you for viewing the detailed overview of Flerie AB's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


Flerie AB Business Description

Traded in Other Exchanges
Address
Berzelius vag 13, Solna, SWE, 171 65
InDex Pharmaceuticals Holding AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment options. The company's main asset is the drug candidate cobitolimod, which is being evaluated in the phase III study as a treatment for moderate to severe ulcerative colitis - a disabling, chronic inflammation of the colon. It has also developed a platform of patent-protected substances, so-called DNA-based Immunomodulatory Sequences, with the potential to be used in the treatment of various immunological diseases.

Flerie AB Headlines

No Headlines